Evaluation of optimal prophylactic antiemetic regimens for doxorubicin-cyclophosphamide chemotherapy. (October 2020) - Yeo, W.; Li, L.; Lau, T.; Lai, K.; Chan, V.; Wong, K.; Yip, C.; Pang, E.; Cheung, M.; Chan, V.; Kwok, C.; Suen, J.; et al.